Insmed Retained Earnings decreased by 2.9% to -$5.80B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 25.6%, from -$4.62B to -$5.80B. Over 5 years (FY 2020 to FY 2025), Retained Earnings shows a downward trend with a 25.2% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase signals strong historical profitability and reinvestment, while a decrease may indicate losses or significant dividend payouts.
This represents the cumulative net income earned by the company since its inception, minus any dividends paid to shareho...
A key metric for all established companies; growth rates are compared against peers to gauge long-term success.
retained_earnings| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$2.04B | -$2.15B | -$2.27B | -$2.31B | -$2.41B | -$2.54B | -$2.70B | -$2.86B | -$3.10B | -$3.26B | -$3.45B | -$3.60B | -$3.90B | -$4.12B | -$4.36B | -$4.62B | -$4.94B | -$5.31B | -$5.64B | -$5.80B |
| QoQ Change | — | -5.5% | -5.2% | -2.0% | -4.1% | -5.5% | -6.3% | -5.9% | -8.6% | -5.1% | -5.7% | -4.6% | -8.3% | -5.6% | -5.7% | -5.9% | -7.0% | -7.5% | -6.2% | -2.9% |
| YoY Change | — | — | — | — | -17.9% | -17.9% | -19.0% | -23.7% | -28.9% | -28.5% | -27.8% | -26.1% | -25.9% | -26.5% | -26.5% | -28.1% | -26.5% | -28.7% | -29.3% | -25.6% |